Why the study?
This review aimed to recapitulate emerging therapeutic molecules and nanodelivery strategies for treating atherosclerosis and restenosis to explore therapeutic approaches for these diseases.
This review summarizes emerging therapeutic molecules and nanodelivery strategies for treating atherosclerosis and restenosis.
Emerging nanodelivery strategies for atherosclerosis merit targeted validation; leaves open clinical translation and efficacy trials.
local administration. They can augment blood circulation time and targeting ability for systemic administration, as well as efficient nanodrug load and precise release. Overall, this review aims to recapitulate the emerging therapeutic molecules and nanodelivery strategies for the treatment of atherosclerosis and restenosis, with the goal of mutual enlightenment in exploring therapeutic approaches for these diseases.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: